BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25712650)

  • 1. The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase β knockout mice.
    Ishisaka M; Tsujii S; Mizoguchi T; Tsuruma K; Shimazawa M; Hara H
    Pharmacol Rep; 2015 Apr; 67(2):275-80. PubMed ID: 25712650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity.
    Ishisaka M; Kakefuda K; Oyagi A; Ono Y; Tsuruma K; Shimazawa M; Kitaichi K; Hara H
    PLoS One; 2012; 7(5):e37058. PubMed ID: 22590645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diacylglycerol kinase β knockout mice exhibit lithium-sensitive behavioral abnormalities.
    Kakefuda K; Oyagi A; Ishisaka M; Tsuruma K; Shimazawa M; Yokota K; Shirai Y; Horie K; Saito N; Takeda J; Hara H
    PLoS One; 2010 Oct; 5(10):e13447. PubMed ID: 20976192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine, an NMDA receptor antagonist, improves working memory deficits in DGKβ knockout mice.
    Kakefuda K; Ishisaka M; Tsuruma K; Shimazawa M; Hara H
    Neurosci Lett; 2016 Sep; 630():228-232. PubMed ID: 27495014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of diacylglycerol kinase η induces lithium-sensitive mania-like behavior.
    Isozaki T; Komenoi S; Lu Q; Usuki T; Tomokata S; Matsutomo D; Sakai H; Bando K; Kiyonari H; Sakane F
    J Neurochem; 2016 Aug; 138(3):448-56. PubMed ID: 27167678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKbeta in neurite spine formation, contributing to cognitive function.
    Shirai Y; Kouzuki T; Kakefuda K; Moriguchi S; Oyagi A; Horie K; Morita SY; Shimazawa M; Fukunaga K; Takeda J; Saito N; Hara H
    PLoS One; 2010 Jul; 5(7):e11602. PubMed ID: 20657643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of diacylglycerol kinase β in the spine formation at distal dendrites of striatal medium spiny neurons.
    Hozumi Y; Kakefuda K; Yamasaki M; Watanabe M; Hara H; Goto K
    Brain Res; 2015 Jan; 1594():36-45. PubMed ID: 25446448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of olanzapine and sodium valproate given alone or as add-on therapy in acute mania. A comparative study.
    Kumar A; Gupta M; Jiloha RC; Tekur U
    Methods Find Exp Clin Pharmacol; 2010 Jun; 32(5):319-24. PubMed ID: 20664822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania.
    Baker RW; Brown E; Akiskal HS; Calabrese JR; Ketter TA; Schuh LM; Trzepacz PT; Watkin JG; Tohen M
    Br J Psychiatry; 2004 Dec; 185():472-8. PubMed ID: 15572737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
    Engel SR; Creson TK; Hao Y; Shen Y; Maeng S; Nekrasova T; Landreth GE; Manji HK; Chen G
    Mol Psychiatry; 2009 Apr; 14(4):448-61. PubMed ID: 18227838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    Tohen M; Chengappa KN; Suppes T; Baker RW; Zarate CA; Bowden CL; Sachs GS; Kupfer DJ; Ghaemi SN; Feldman PD; Risser RC; Evans AR; Calabrese JR
    Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
    Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
    Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
    Novick D; Gonzalez-Pinto A; Haro JM; Bertsch J; Reed C; Perrin E; Tohen M;
    Pharmacopsychiatry; 2009 Jul; 42(4):145-52. PubMed ID: 19585393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons.
    Hozumi Y; Watanabe M; Otani K; Goto K
    BMC Neurosci; 2009 Aug; 10():99. PubMed ID: 19691842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.
    Weiss S; Nosten-Bertrand M; McIntosh JM; Giros B; Martres MP
    Neuropsychopharmacology; 2007 Dec; 32(12):2465-78. PubMed ID: 17375139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
    Spina E; D'Arrigo C; Santoro V; Muscatello MR; Pandolfo G; Zoccali R; Diaz FJ; de Leon J
    Ther Drug Monit; 2009 Dec; 31(6):758-63. PubMed ID: 19865002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
    Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
    J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.